How to choose a food supplement contract manufacturer

Choosing a contract manufacturer is probably the most structural decision in the development of a food supplement. That partner will determine the quality of your formula, your time to market, your cost price and, in the end, the credibility of your brand.

Having audited more than 250 industrial partners, suppliers and contract manufacturers in France and in Poland, here is what I have learned about what really separates a good manufacturer from a bad one, and about the mistakes that cost the most.

1. Dosage form specialisation, the number one criterion and the most underestimated

Not every contract manufacturer masters the same forms. A plant that excels at dry capsules can be completely out of its depth on a gummy or a functional drink. Before any negotiation, the first question is simple. Does this manufacturer produce regularly and at volume the dosage form you are targeting?

The most common dosage forms and their industrial specifics:

• Capsules and tablets, the best mastered dosage form in France, accessible MOQs, short lead times
• Powders and sticks, requiring specific dosing and packaging lines
• Gummies, a complex cooking process, critical thermal compatibility of the actives, and very few genuinely expert manufacturers in France
• Softgels and oil capsules, a specific encapsulation process and rare expertise
• Functional drinks and shots, aseptic filling or pasteurisation, high hygiene constraints
• Effervescent and orodispersible tablets, complex formulation and sensitivity to humidity

My recommendation is to always ask for a list of live product references on your target dosage form, with real production volumes. A manufacturer that “can do it” is not the same thing as a manufacturer that does it regularly.

2. Ingredient qualification, the part nobody tells you about

This is the blind spot of most launches. People talk a lot about certifications and lead times, and rarely about what happens upstream, namely the real quality of the ingredients your manufacturer is going to put into your formula.

Based on my field analyses and my HPLC testing (High Performance Liquid Chromatography) on batches coming from common suppliers, only 20% of the botanical extracts tested genuinely comply with their stated specifications. The remaining 80% are underdosed, poorly standardised or, worse, adulterated with cheaper replacement substances.

What that means in practice:

• A curcumin extract declared at 95% curcuminoids may actually contain only 40%
• A griffonia extract (5-HTP) may be cut with common amino acids to reach the theoretical dosage
• A rhodiola extract may not contain the active rosavins you expect

Good practice is to systematically require third-party certificates of analysis (COA) on every batch and, for critical actives, to commission an independent HPLC analysis. That is an investment of 300 to 800 euros per ingredient which can save you from launching a product whose efficacy you cannot defend.

Also check that your manufacturer carries out regular supplier visits, or that it lets you come along. A good industrial partner does not choose its raw materials from a catalogue alone.

3. Quality certifications, reading between the lines

Certifications are a basic filter, not an absolute guarantee. Here is how to read them:

• ISO 22000, food safety management. A serious standard, but an expensive one, and certified manufacturers pass that cost on in their prices
• BRC and IFS, retail certifications, required by large retailers and by some e-commerce players
• GMP (Good Manufacturing Practice), the pharmaceutical framework and the highest level of requirement. Necessary if you are targeting pharmaceutical distributors or the Swiss market
• Organic and Ecocert, if you are developing a certified organic range, check that the manufacturer has dedicated lines or a validated cleaning protocol to avoid cross contamination

A manufacturer without certification is not necessarily bad, and a certified manufacturer is not necessarily good. What counts is the rigour of its quality system day to day: batch traceability, handling of non-conformities, frequency of internal audits.

4. MOQ, lead times and costs, to be anticipated from the brief

These three parameters are interdependent and must be discussed at the start, not at the end of the negotiation.

Indicative MOQs (minimum order quantities):

• Capsules and tablets, 50,000 to 100,000 units, which is 1,000 to 2,000 pill boxes of 60 capsules
• Powders and sticks, often 500 to 1,000 kg of finished product
• Gummies, rarely below 5,000 finished units for a bespoke formula
• Drinks and shots, variable depending on the packaging, often 10,000 units minimum

Average lead times. Allow 10 to 14 weeks between the firm order and delivery, across all dosage forms. On complex formulas such as gummies, multilayer tablets or liquid forms, plan for 16 to 20 weeks for a first production run.

On costs. Be wary of quotations that look too attractive. An unusually low price almost always hides a concession somewhere, on raw material quality, on testing, or on production lead times. The right indicator is not the headline price but the quality to safety to cost to lead time ratio.

5. France and Poland, two complementary logics

This is an angle few consultants master, because it calls for hands-on knowledge of both markets.

French manufacturers offer smoother communication, often shorter lead times, and a close relationship that makes plant visits and mid-development adjustments easier. Quality requirements there are very high, but labour costs feed through into the cost price.

Polish manufacturers, which I know well because I work with them regularly, often make it possible to cut production costs by 20 to 40% at equivalent quality on certain dosage forms. Poland is an underestimated European nutraceutical hub. Several manufacturers there hold ISO 22000 and GMP certification and already work with major French and German brands.

The strategy I apply for my clients is to systematically compare equivalent quotations from both markets, taking logistics costs and communication constraints into account. On simple high-volume formulas, the cost difference can change the profitability of a launch.

6. Think partnership, not supplier

The right manufacturer is not only the one that produces your first batch. It is the one that will support your reformulations, absorb your growth in volume, and warn you when an ingredient comes under supply pressure.

The signals that point to a good long-term partner:

• They flag raw material problems to you proactively
• They propose alternatives when an ingredient is out of stock
• They accept plant visits without staging them in advance
• Their R&D team is available to co-develop, not only to execute
• They are transparent about their margins and their cost structure

Conclusion

Choosing a contract manufacturer does not come down to comparing quotations on one dosage form. It is a strategic decision that commits the quality of your products, your brand reputation and your long-term profitability.

The technical criteria, meaning ingredient quality verified by HPLC, appropriate certifications and genuine dosage form capability, have to come before price. And the partnership dimension should be assessed from the very first contact.

If you would like support in selecting and qualifying your industrial partners in France and in Poland, let us take 30 minutes to frame your project.